Breast Cancer Research and Treatment

, Volume 110, Issue 3, pp 397–409 | Cite as

Benign proliferative epithelial disorders of the breast: a review of the epidemiologic evidence

  • Stephanie A. Navarro Silvera
  • Thomas E. Rohan
Review

References

  1. 1.
    Rohan TE, Kandel RA (2002) Breast. In: Franco EL, Rohan TE (eds) Cancer precursors: epidemiology, detection, and prevention. Springer-Verlag, New York, 232–248Google Scholar
  2. 2.
    Soini I, Aine R, Lauslahti K, Hakama M (1981) Independent risk factors of benign and malignant breast lesions. Am J Epidemiol 114:507–514PubMedGoogle Scholar
  3. 3.
    Lakhani SR (1999) The transition from hyperplasia to invasive carcinoma of the breast. J Pathol 187:272–278PubMedCrossRefGoogle Scholar
  4. 4.
    Miller AB, Soule HD, Tait L, Pauley RJ, Wolman SR, Dawson PJ, Heppner GH (1993) Xenograph model of progressive human proliferative breast disease. J Natl Cancer Inst 85:1725–1732PubMedCrossRefGoogle Scholar
  5. 5.
    Davies BR, Platt-Higgins AM, Schmidt G Rudland PS (1999) Development of hyperplasias, preneoplasias, and mammary tumors in mmtv-c-erbb-2 and mmtv-tffα transgenic rats. Am J Pathol 155:303–314PubMedGoogle Scholar
  6. 6.
    Li Y, Hively WP, Varmus HE (2000) Use of mmtv-wnt-1 transgenic mice for studying the genetic basis of breast cancer. Oncogene 19:1002–1009PubMedCrossRefGoogle Scholar
  7. 7.
    Schnitt SJ (2003) Benign breast disease and breast cancer risk. Am J Surg Pathol 27:836–841PubMedCrossRefGoogle Scholar
  8. 8.
    Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton III LJ and Visscher DW (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353:229–237PubMedCrossRefGoogle Scholar
  9. 9.
    Worsham MJ, Abrams J, Raju U, Kapke A, Lu M, Cheng J, Mott D, Wolman SR (2007) Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population. Breast J 13:115–121PubMedCrossRefGoogle Scholar
  10. 10.
    Marshall LM, Hunter DJ, Connolly JL, Schnitt SK, Byrne C, London SJ, Colditz G (1997) Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 6:297–301PubMedGoogle Scholar
  11. 11.
    Wang DY, Fentiman IS (1985) Epidemiology and endocrinology of benign breast disease. Breast Cancer Res Treat 6:5–36PubMedCrossRefGoogle Scholar
  12. 12.
    Rohan TE, Hartwick W, Miller AB, Kandel RA (1998) Immunohistochemical detection of c-erbb-2 and p53 proteins in benign breast disease and breast cancer risk. J Natl Cancer Inst 90:1262–1269PubMedCrossRefGoogle Scholar
  13. 13.
    Franz VK, Pickren JW, Melcher GW, Auchincloss H Jr (1951) Incidence of chronic cystic disease in so-called normal breasts. Cancer 4:762–783CrossRefGoogle Scholar
  14. 14.
    Sloss PT, Bennett WA, Clagett OT (1957) Incidence in normal breasts of features associated with chronic cystic mastitis. Am J Pathol 33:1181–1191PubMedGoogle Scholar
  15. 15.
    Sandison AT (1962) An autopsy study of the adult human breast. US GPO, Washington, DCGoogle Scholar
  16. 16.
    Humphrey LJ, Swerdlow M (1966) Histologic changes in clinically normal breasts at postmortem examination. Arch Surg 92:192–193PubMedGoogle Scholar
  17. 17.
    Kramer WM, Rush Jr BF (1973) Mammary duct proliferation in the elderly. A histopathologic study. Cancer 31:130–137PubMedCrossRefGoogle Scholar
  18. 18.
    Sasano N, Tateno H, Stemmerman GN (1978) Volume and hyperplastic lesions of breasts of japanese women in hawaii and japan. Prev Med 7:196–204PubMedCrossRefGoogle Scholar
  19. 19.
    Nielson M, Jenson J, Anderson J (1984) Precancerous and cancerous breast lesions during lifetime and at autopsy. A study of 83 women. Cancer 54:612–615CrossRefGoogle Scholar
  20. 20.
    Alpers CE, Wellings SR (1985) The prevalence of carcinoma in situ in normal and cancer-associated breasts. Hum Pathol 16:796–807PubMedCrossRefGoogle Scholar
  21. 21.
    Bhathal PS, Brown RW, Lesueur GC, Russell IS (1985) Frequency of benign and malignant breast lesions in 207 consecutive autopsies in australian women. Br J Cancer 51:271–278PubMedGoogle Scholar
  22. 22.
    Nielson M, Thomsen JL, Primdahl S, Dyreborg U, Andersen JA (1987) Breast cancer and atypia among young and middle aged women: A study of 110 medicolegal autopsies. Br J Cancer 56:814–819Google Scholar
  23. 23.
    Sarnelli R, Squartini F (1991) Fibrocstic condition and "at risk" lesions in asymptomatic breasts: a morphologic study of postmenopausal women. Clin Exp Obstet Gynecol 18:271–279PubMedGoogle Scholar
  24. 24.
    Ory H, Cole P, MacMahon B, Hoover R (1976) Oral contraeptive and reduced risk of benign breast disease. N Engl J Med 249:419–422CrossRefGoogle Scholar
  25. 25.
    Cole P, Elwood JM, Kaplan SD (1978) Incidence rates and risk of factors of benign breast neoplasms. Am J Epidemiol 108:112–120PubMedGoogle Scholar
  26. 26.
    Brinton LA, Vessey MP, Flavel R, Yeates D (1981) Risk factors for benign breast disease. Am J Epidemiol 113:203–214PubMedGoogle Scholar
  27. 27.
    Fleming NT, Armstrong BK, Sheiner HJ (1982) The comparative epidemiology of benign breast lumps and breast cancer in western australia. Int J Cancer 30:147–152PubMedCrossRefGoogle Scholar
  28. 28.
    Heinemann K, Thiel C, Mohner S, Lewis MA, Raff T, Kuhl-Habich D, Heinemann LAJ (2003) Benign gynecological tumors: Estimate incidence results of the german gohort study on women’s health. Eur J Obstet Gynecol Reprod Biol 107:78–80PubMedCrossRefGoogle Scholar
  29. 29.
    Cook MG, Rohan TE (1985) The patho-epidemiology of benign proliferative epithelial disorders of the female breast. J Path 146:1–15PubMedCrossRefGoogle Scholar
  30. 30.
    Lance LL (1981) Risk factors for benign breast disease. Am J Epidemiol 114:606–607PubMedGoogle Scholar
  31. 31.
    Parazzini F, La Vecchia C, Franceschi S, Decarli A, Gallus G, Regallo M, Liberati A, Tognoni G (1991) Risk factors for pathologically confirmed benign breast disease. Am J Epidemiol 120:115–122Google Scholar
  32. 32.
    Parazzini F, Perraroni M, La Vecchia C, Baron JA, Levi F, Franceschi S, Decarli A (1991) Smoking habits and risk of benign breast disease. Int J Epidemiol 20:430–434PubMedCrossRefGoogle Scholar
  33. 33.
    Berkowitz GS, Kelsey JL, LiVolsi VA, Holford TR, Merino MJ, Ort S, O’Connor TZ, White C (1985) Risk factors for fibrocystic breast disease and its histopathologic components. J Natl Cancer Inst 75:43–50PubMedGoogle Scholar
  34. 34.
    Pastides H, Kelsey JL, Holford TR, LiVolsi VA (1985) An epidemiologic study of fibrocystic breast disease with reference to ductal epithelial atypia. Am J Epidemiol 121:440–447PubMedGoogle Scholar
  35. 35.
    Bright RA, Morrison AS, Brisson J, Burstein NA, Sadowsky NL, Kopans DB, Meyer JE (1989) Histologic and mammographic specificity of risk factors for benign breast disease. Cancer 64:653–657PubMedCrossRefGoogle Scholar
  36. 36.
    Rohan TE, Cook MG (1989) Alcohol consumption and risk of benign proliferative epithelial disorders of the breast in women. Int J Cancer 43:631–636PubMedCrossRefGoogle Scholar
  37. 37.
    Rohan TE, Cook MG, Baron JA (1989) Cigarette smoking and benign proliferative epithelial disorders of the breast in women: A case–control study. J Epidemiol Community Health 43:362–368PubMedCrossRefGoogle Scholar
  38. 38.
    Ingram DM, Nottage E, Ng S, Sparrow L, Roberts A, Willcox D (1989) Obesity and breast disease. The role of the female sex hormone. Cancer 64:1049–1053Google Scholar
  39. 39.
    Ingram DM, Nottage E, Roberts T (1991) The role of diet in the development of breast cancer: A case–control study of patients with breast cancer, benign epithelial hyperplasia and fibrocystic disease of the breast. Br J Cancer 64:187–191PubMedGoogle Scholar
  40. 40.
    London SJ, Stein EA, Henderson IC, Stampfer MJ, Wood WC, Remine S, Dmochowski JR, Robert NJ, Willett WC (1992) Carotenoids, retinol, and vitamin e and risk of proliferative benign breast disease and breast cancer. Cancer Causes Control 3:503–512PubMedCrossRefGoogle Scholar
  41. 41.
    Minami Y, Ohuchi N, Taeda y, Fukao A, Hisamichi S (1998) Risk factors for benign breast disease according to histopathological type: Comparisons with risk factors for breast disease. Jpn J Cancer Res 89:116–123PubMedGoogle Scholar
  42. 42.
    Hsieh CC, Walker AM, Trapido EJ, Crosson AW, MacMahon B (1984) Age at first birth and breast atypia. Int J Cancer 33:309–312PubMedCrossRefGoogle Scholar
  43. 43.
    Rohan TE, L’Abbe KA Cook MG (1992) Oral contraceptives and risk of benign proliferative epithelial disorders of the breast. Int J Cancer 50:891–894PubMedCrossRefGoogle Scholar
  44. 44.
    LiVolsi VA, Stadel BV, Kelsey JL, Holford TR, White C (1978) Fibrocystic breast disease in oral-contraceptive users. A histopathological evaluation of epithelial atypia. N Engl J Med 299:381–385PubMedCrossRefGoogle Scholar
  45. 45.
    Pastides H, Kelsey JL, LiVolsi VA, Holford TR, Fischer DB, Goldenberg IS (1983) Oral contraceptive use and fibrocystic breast disease with special reference to its histopathology. J Natl Cancer Inst 71:5–9PubMedGoogle Scholar
  46. 46.
    Berkowitz GS, Kelsey JL, Merino MJ, Holford TR, Hildreth NG, Ort S, O’Connor TZ, White C (1984) Exogenous hormone use and fibrocystic breast disease by histopathologic component. Int J Cancer 34:443–449PubMedCrossRefGoogle Scholar
  47. 47.
    Rohan TE, Miller AB (1999) Hormone replacement therapy and risk of benign proliferative epithelial disorders of the breast. Eur J Epidemiol 8:123–130Google Scholar
  48. 48.
    Rohan TE, Cook MG, Potter JD, McMichael AJ (1990) A case–control study of diet and benign proliferative epithelial disorders of the breast. Cancer Res 50:3176–3181PubMedGoogle Scholar
  49. 49.
    London SJ, Sacks FM, Stampfer MJ, Henderson AC, Maclure M, Tomita A, Wood WC, Remine S, Robert NJ, Dmochowski JR, Willett WC (1993) Fatty acid composition of the subcutaneous adipose tissue and risk of proliferative benign breast disease and breast cancer. J Natl Cancer Inst 85:785–793PubMedCrossRefGoogle Scholar
  50. 50.
    Baghurst PA, Rohan TE (1995) Dietary fiber and risk of benign proliferative epithelial disorders of the breast. Int J Cancer 63:481–485PubMedCrossRefGoogle Scholar
  51. 51.
    Lubin F, Wax Y, Ron E, Black M, Chetrit A, Rosen N, Alfandary E, Modan B (1989) Nutritional factors associated with benign breast disease etiology: A case–control study. Am J Clin Nutr 50:551–556PubMedGoogle Scholar
  52. 52.
    Friedenreich CM, Rohan TE (1994) Recreational physical activity and risk of benign proliferative epithelial disorders of the breast in women. Eur J Cancer Prev 3:465–471PubMedCrossRefGoogle Scholar
  53. 53.
    Wu C, Ray RM, Lin MG, Neilann DLG, Korner NK, Nelson ZC, Lampe JW, Hu YW, Shannon J, Stalsberg H, Li W, Fitzgibbons PL, Porter P, Patterson RE, Satia JA, Thomas DB (2004) A case–control study of risk factors for fibrocystic breast conditions. Shanghai nutrition and breast disease study, china, 1995–2000. Am J Epidemiol 160:945–960PubMedCrossRefGoogle Scholar
  54. 54.
    Friedenreich CM, Bryant HE, Alexander F, Hugh J, Danyluk J, Page DL (2000) Risk factors for benign proliferative breast disease. Int J Epidemiol 29:637–644PubMedCrossRefGoogle Scholar
  55. 55.
    Rohan TE, Jain M, Miller AB (1998) A case–cohort study of diet and risk of benign proliferative epithelial disorders of the breast (canada). Cancer Causes Control 9:19–27PubMedCrossRefGoogle Scholar
  56. 56.
    Rohan TE, Miller AB (1999) A cohort study of oral contraceptive use and risk of benign breast disease. Int J Cancer 82:191–196PubMedCrossRefGoogle Scholar
  57. 57.
    Rohan TE (1999) Cigarette smoking and risk of benign proliferative epithelial disorders of the breast. Eur J Epidemiol 15:529–535PubMedCrossRefGoogle Scholar
  58. 58.
    Rohan TE, Jain M, Miller AB (1998) Alcohol consumption and risk of benign proliferative epithelial disorders of the breast: A case–cohort study. Public Health Nutr 1:139–145PubMedCrossRefGoogle Scholar
  59. 59.
    Webb PM, Byrne C, Schnitt SJ, Connolly JL, Jacobs TW, Baer HJ, Willett WC, Colditz G (2004) A prospective study of diet and benign breast disease. Cancer Epidemiol Biomarkers Prev 13:1106–1113PubMedGoogle Scholar
  60. 60.
    Cui Y, Page DL, Chlebowski RT, Beresford SA, Hendrix SL, Lane DS, Rohan TE (2007) Alcohol and folate consumption and risk of benign proliferative epithelial disorders of the breast. Int J Cancer online advance of print, http://www3.interscience.wiley.com/cgi-bin/fulltext/114274175/HTMLSTARTGoogle Scholar
  61. 61.
    Cui Y, Page DL, Chlebowski RT, Hsia J, Hubbell FA, Johnson KC, Rohan TE (2007) Cigarette smoking and risk of benign proliferative epithelial disorders of the breast in the women’s health initiative. Cancer Causes Control 18:431–438PubMedCrossRefGoogle Scholar
  62. 62.
    Hislop TG, Band PR, Deschamps M, Ng V, Coldman AJ, Worth AJ, Labo T (1990) Diet and histologic types of benign breast disease defined by subsequent risk of breast cancer. Am J Epidemiol 131:263–270PubMedGoogle Scholar
  63. 63.
    Hankinson SE, Hunter DJ (2002) Breast cancer. In: Adami HO, Hunter DJ, Tricholopoulos D (eds) Textbook of cancer epidemiology. Oxford, Oxford University Press, pp 301–339Google Scholar
  64. 64.
    World Cancer Research Fund and American Institute for Cancer Research (1997) Food, nutrition and the prevention of cancer: a global perspective. American Institute for Cancer Research, Washington, DCGoogle Scholar
  65. 65.
    IARC (2002) Handbooks on cancer prevention, weight control and physical activity. Lyon, IARC PressGoogle Scholar
  66. 66.
    . Huang Z, Hankinson SE, Colditz G, Stampfer MJ, Manson JE, Hennekens CH, Rosner B, Speizer FE, Willett WC (1997) Dual effects of weight and weight gain on breast cancer. JAMA 278:1407–1411PubMedCrossRefGoogle Scholar
  67. 67.
    Hunter DJ, Willett WC (1993) Diet, body size, and breast cancer. Epidemiol Rev 15:110–132PubMedGoogle Scholar
  68. 68.
    Singletary SE (2003) Rating the risk factors for breast cancer. Ann Surg 237:474–482PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Stephanie A. Navarro Silvera
    • 1
  • Thomas E. Rohan
    • 2
  1. 1.Health and Nutrition SciencesMontclair State UniversityMontclairUSA
  2. 2.Department of Epidemiology and Population HealthAlbert Einstein College of MedicineBronxUSA

Personalised recommendations